نتائج البحث - Faiz Anwer

تنقيح النتائج
  1. 1
    Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists

    Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists حسب Omer S. Ashruf, Jasmin Hundal, Ali Mushtaq, David C. Kaelber, Faiz Anwer, Abhay Singh

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Safety of CAR-T Cell Therapy in Patients With Renal Failure/Acute Kidney Injury: Focused Review

    Safety of CAR-T Cell Therapy in Patients With Renal Failure/Acute Kidney Injury: Focused Review حسب Israr Khan, Nida Khan, Natalie Wolfson, Kawthar Djebabria, Mohammad Ebad Ur Rehman, Faiz Anwer

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Waldenström Macroglobulinemia: Review of Pathogenesis and Management

    Waldenström Macroglobulinemia: Review of Pathogenesis and Management حسب Seongseok Yun, Ariel C. Johnson, Onyemaechi Okolo, Stacy Arnold, Ali McBride, Ling Zhang, Rachid Baz, Faiz Anwer

    منشور في 2017
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Toxicity Profile of Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapies in Multiple Myeloma: Pathogenesis, Prevention and Management

    Toxicity Profile of Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapies in Multiple Myeloma: Pathogenesis, Prevention and Management حسب Mariam Markouli, Fauzia Ullah, Serhan Ünlü, Najiullah Omar, Nerea Lopetegui‐Lia, Marissa Duco, Faiz Anwer, Shahzad Raza, Danai Dima

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    A Review of Autologous Stem Cell Transplantation in Lymphoma

    A Review of Autologous Stem Cell Transplantation in Lymphoma حسب Umar Zahid, Faisal Akbar, Akshay Amaraneni, Muhammad Husnain, Onyee Chan, Irbaz Bin Riaz, Ali McBride, Ahmad Iftikhar, Faiz Anwer

    منشور في 2017
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management

    Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management حسب Areez Shafqat, Hassan Elmaleh, Ali Mushtaq, Zaina Firdous, Omer S. Ashruf, Debduti Mukhopadhyay, Maheen Ahmad, Mahnoor Ahmad, Shahzad Raza, Faiz Anwer

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy

    Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy حسب Kevin R. Kelly, Claudia M. Espitia, Weiguo Zhao, Kaijin Wu, Valeria Visconte, Faiz Anwer, Christine M. Calton, Jennifer S. Carew, Steffan T. Nawrocki

    منشور في 2017
    احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Brentuximab vedotin for treatment of non-Hodgkin lymphomas: A systematic review

    Brentuximab vedotin for treatment of non-Hodgkin lymphomas: A systematic review حسب Garrett K. Berger, Ali McBride, Stephanie Lawson, Kelsey Royball, Seongseok Yun, Kevin Gee, Irbaz Bin Riaz, Ahlam Saleh, Soham D. Puvvada, Faiz Anwer

    منشور في 2016
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Donor Origin CAR T Cells: Graft Versus Malignancy Effect Without GVHD, a Systematic Review

    Donor Origin CAR T Cells: Graft Versus Malignancy Effect Without GVHD, a Systematic Review حسب Faiz Anwer, Al-Aman Shaukat, Umar Zahid, Muhammad Husnain, Ali McBride, Daniel O. Persky, Melissa Siaw Han Lim, Nida Hasan, Irbaz Bin Riaz

    منشور في 2017
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Role and mechanism of autophagy‐regulating factors in tumorigenesis and drug resistance

    Role and mechanism of autophagy‐regulating factors in tumorigenesis and drug resistance حسب Rana Muhammad Usman, Faryal Razzaq, Arshia Akbar, Arafat Ali Farooqui, Ahmad Iftikhar, Azka Latif, Hamza Hassan, Jianjun Zhao, Jennifer S. Carew, Steffan T. Nawrocki, Faiz Anwer

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Blocking “don't eat me” signal of CD47-SIRPα in hematological malignancies, an in-depth review

    Blocking “don't eat me” signal of CD47-SIRPα in hematological malignancies, an in-depth review حسب Atlantis Dawn Russ, Anh Hua, W.R. Montfort, Bushra Rahman, Irbaz Bin Riaz, Muhammad Umar Khalid, Jennifer S. Carew, Steffan T. Nawrocki, Daniel O. Persky, Faiz Anwer

    منشور في 2018
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice

    Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice حسب Danai Dima, Fauzia Ullah, Sandra Mazzoni, Louis Williams, Beth Faiman, Austin Kurkowski, Chakra P Chaulagain, Shahzad Raza, Christy Samaras, Jason Valent, Jack Khouri, Faiz Anwer

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome–Positive Acute Lymphoblast Leukemia: A Systematic Review

    Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome–Positive Acute Lymphoblast Leukemia: A Systematic Review حسب Zabih Warraich, Pavan Tenneti, Theresa Thai, Anne Hubben, Hina Amin, Ali McBride, Sami Ullah, Abdul Hannan, Faiza Hassan Warraich, Navneet S. Majhail, Matt Kalaycio, Faiz Anwer

    منشور في 2019
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Systemic AL amyloidosis: current approach and future direction

    Systemic AL amyloidosis: current approach and future direction حسب Maroun Bou Zerdan, Lewis Nasr, Farhan Khalid, Sabine Allam, Youssef Bouferraa, Saba Batool, Muhammad Tayyeb, Shubham Adroja, Mahinbanu Mammadii, Faiz Anwer, Shahzad Raza, Chakra P Chaulagain

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort study

    Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort study حسب Fahrettin Covut, Ramsha Ahmed, Sanchit Chawla, Frank Ricaurte, Christy Samaras, Faiz Anwer, Alex V. Mejia Garcia, Dana E. Angelini, Sandra Mazzoni, Beth Faiman, Jason Valent, Jack Khouri

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma

    Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma حسب James A. Davis, Danai Dima, Nausheen Ahmed, Shaun DeJarnette, Joseph P. McGuirk, Xuefei Jia, Shahzad Raza, Jack Khouri, Jason Valent, Faiz Anwer, Al‐Ola Abdallah, Hamza Hashmi

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Current Novel Targeted Therapeutic Strategies in Multiple Myeloma

    Current Novel Targeted Therapeutic Strategies in Multiple Myeloma حسب Cindy Hsin-Ti Lin, Muhammad Junaid Tariq, Fauzia Ullah, Aishwarya Sannareddy, Farhan Khalid, Hasan Abbas, Abbas Bader, Christy Samaras, Jason Valent, Jack Khouri, Faiz Anwer, Shahzad Raza, Danai Dima

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Real-World Safety and Efficacy of Teclistamab for Patients with Heavily Pretreated Relapsed-Refractory Multiple Myeloma

    Real-World Safety and Efficacy of Teclistamab for Patients with Heavily Pretreated Relapsed-Refractory Multiple Myeloma حسب Danai Dima, James A. Davis, Nausheen Ahmed, Aishwarya Sannareddy, Hira Shaikh, Zahra Mahmoudjafari, Jack Khouri, Gurbakhash Kaur, Christopher Strouse, Jason Valent, Larry D. Anderson, Faiz Anwer, Al‐Ola Abdallah, Hamza Hashmi

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine

    The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine حسب Steffan T. Nawrocki, Yingchun Han, Valeria Visconte, Bartlomiej Przychodzen, Claudia M. Espitia, James G. Phillips, Faiz Anwer, Anjali S. Advani, Hetty E. Carraway, Kevin R. Kelly, Mikkael A. Sekeres, Jaroslaw P. Maciejewski, Jennifer S. Carew

    منشور في 2019
    احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Venous thromboembolism risk with contemporary lenalidomide‐based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta‐analysis

    Venous thromboembolism risk with contemporary lenalidomide‐based regimens despite thromboprophylaxis in multiple myeloma: A systematic review and meta‐analysis حسب Rajshekhar Chakraborty, Irbaz Bin Riaz, Saad Ullah Malik, Naimisha Marneni, Alex Mejia Garcia, Faiz Anwer, Alok A. Khorana, S. Vincent Rajkumar, Shaji Kumar, M. Hassan Murad, Zhen Wang, Safi U. Khan, Navneet S. Majhail

    منشور في 2020
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: